Filing Details
- Accession Number:
- 0001209191-15-061523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-17 16:36:32
- Reporting Period:
- 2015-07-15
- Filing Date:
- 2015-07-17
- Accepted Time:
- 2015-07-17 16:36:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Pharma Plc | HZNP | Pharmaceutical Preparations (2834) | 272179987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1230482 | W Jeffrey Sherman | C/O Horizon Pharma Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | Evp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2015-07-15 | 24,437 | $2.40 | 137,319 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2015-07-15 | 24,437 | $35.55 | 112,882 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2015-07-15 | 2,450 | $4.96 | 115,332 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2015-07-15 | 2,450 | $35.55 | 112,882 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2015-07-15 | 24,437 | $0.00 | 24,437 | $2.40 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2015-07-15 | 2,450 | $0.00 | 2,450 | $4.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,563 | 2023-01-01 | No | 4 | M | Direct | |
| 51,171 | 2021-12-07 | No | 4 | M | Direct |
Footnotes
- Includes 10,549 ordinary shares of the Issuer acquired by the reporting person on June 1, 2015 pursuant to an employee stock purchase program.
- The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on May 13, 2015.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.09 to $35.92 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The stock option vests in 48 equal monthly installments following the date of grant.
Billionaire Hedge Funds
